NK EVs have been shown to be enriched in the tumor suppressor miR-186, which was downregulated in MYCN-amplified neuroblastoma cell lines and in tumor lesions from high-risk patients vs. low-risk patients [168]. Here, MYCN is linked to neoplasm.